Inaktiver Wert

Cadence Pharmaceuticals, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06.05.14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28.02.14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12.02.14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11.02.14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13.01.14

Manager	Titel	Alter	Seit
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01.05.06

Aufsichtsräte	Titel	Alter	Seit
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19.03.14

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	+2,22 %	94,37 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	-0,66 %	38,14 Mrd.
BIOGEN INC.	-13,57 %	32,56 Mrd.
UCB	+76,24 %	28,24 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-12,73 %	15,98 Mrd.
INCYTE CORPORATION	-2,15 %	13,82 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13,59 %	11,57 Mrd.
ALTEOGEN INC.	+158,88 %	10,52 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-52,04 %	9,89 Mrd.